<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.parasitesandvectors.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Parasites &amp; Vectors - Most accessed articles</title>
        <link>http://www.parasitesandvectors.com</link>
        <description>The most accessed research articles published by Parasites &amp; Vectors</description>
        <dc:date>2010-03-11T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/3/1/5" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/1/1/25" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/3/1/12" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/3/1/10" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/3/1/14" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/3/1/13" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/3/1/11" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/1/1/3" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/3/1/4" />
                                <rdf:li rdf:resource="http://www.parasitesandvectors.com/content/3/1/16" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.parasitesandvectors.com/content/3/1/5">
        <title>History of the discovery of the malaria parasites and their vectors</title>
        <description>Malaria is caused by infection with protozoan parasites belonging to the genus Plasmodium transmitted by female Anopheles species mosquitoes. Our understanding of the malaria parasites begins in 1880 with the discovery of the parasites in the blood of malaria patients by Alphonse Laveran. The sexual stages in the blood were discovered by William MacCallum in birds infected with a related haematozoan, Haemoproteus columbae, in 1897 and the whole of the transmission cycle in culicine mosquitoes and birds infected with Plasmodium relictum was elucidated by Ronald Ross in 1897. In 1898 the Italian malariologists, Giovanni Battista Grassi, Amico Bignami, Giuseppe Bastianelli, Angelo Celli, Camillo Golgi and Ettore Marchiafava demonstrated conclusively that human malaria was also transmitted by mosquitoes, in this case anophelines. The discovery that malaria parasites developed in the liver before entering the blood stream was made by Henry Shortt and Cyril Garnham in 1948 and the final stage in the life cycle, the presence of dormant stages in the liver, was conclusively demonstrated in 1982 by Wojciech Krotoski. This article traces the main events and stresses the importance of comparative studies in that, apart from the initial discovery of parasites in the blood, every subsequent discovery has been based on studies on non-human malaria parasites and related organisms.</description>
        <link>http://www.parasitesandvectors.com/content/3/1/5</link>
                <dc:creator>Francis Cox</dc:creator>
                <dc:source>Parasites &amp; Vectors 2010, 3:5</dc:source>
        <dc:date>2010-02-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-3-5</dc:identifier>
        <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2010-02-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/1/1/25">
        <title>Canine vector-borne diseases in Brazil</title>
        <description>Canine vector-borne diseases (CVBDs) are highly prevalent in Brazil and represent a challenge to veterinarians and public health workers, since some diseases are of great zoonotic potential. Dogs are affected by many protozoa (e.g., Babesia vogeli, Leishmania infantum, and Trypanosoma cruzi), bacteria (e.g., Anaplasma platys and Ehrlichia canis), and helminths (e.g., Dirofilaria immitis and Dipylidium caninum) that are transmitted by a diverse range of arthropod vectors, including ticks, fleas, lice, triatomines, mosquitoes, tabanids, and phlebotomine sand flies. This article focuses on several aspects (etiology, transmission, distribution, prevalence, risk factors, diagnosis, control, prevention, and public health significance) of CVBDs in Brazil and discusses research gaps to be addressed in future studies.</description>
        <link>http://www.parasitesandvectors.com/content/1/1/25</link>
                <dc:creator>Filipe Dantas-Torres</dc:creator>
                <dc:source>Parasites &amp; Vectors 2008, 1:25</dc:source>
        <dc:date>2008-08-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-1-25</dc:identifier>
        <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>25</prism:startingPage>
        <prism:publicationDate>2008-08-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/3/1/12">
        <title>Attracting, trapping and killing disease-transmitting mosquitoes using odor-baited stations -The Ifakara Odor-Baited Stations</title>
        <description>Background:
To accelerate efforts towards control and possibly elimination of mosquito-borne diseases such as malaria and lymphatic filariasis, optimally located outdoor interventions could be used to complement existing intradomicilliary vector control methods such as house spraying with insecticides and insecticidal bednets.
Methods:
We describe a new odor-baited station for trapping, contaminating and killing disease-transmitting mosquitoes. This device, named the &apos;Ifakara Odor-baited Station&apos; (Ifakara OBS), is a 4 m3 hut-shaped canvas box with seven openings, two of which may be fitted with interception traps to catch exiting mosquitoes. It is baited with synthetic human odors and may be augmented with contaminants including toxic insecticides or biological agents.
Results:
In field trials where panels of fabric were soaked in 1% pirimiphos-methyl solution and suspended inside the Ifakara OBS, at least 73.6% of Anopheles arabiensis, 78.7% of Culex and 60% of Mansonia mosquitoes sampled while exiting the OBS, died within 24 hours. When used simply as a trap and evaluated against two existing outdoor traps, Ifakara Tent trap and Mosquito Magnet-X&#174;, the OBS proved more efficacious than the Ifakara Tent trap in catching all mosquito species found (P &lt; 0.001). Compared to the Mosquito Magnet-X&#174;, it was equally efficacious in catching An. arabiensis (P = 0.969), but was less efficacious against Culex (P &lt; 0.001) or Mansonia species (P &lt; 0.001).
Conclusion:
The Ifakara OBS is efficacious against disease-carrying mosquitoes including the malaria vector, An. arabiensis and Culicine vectors of filarial worms and arboviruses. It can be used simultaneously as a trap and as a contamination or killing station, meaning most mosquitoes which escape trapping would leave when already contaminated and die shortly afterwards. This technique has potential to complement current vector control methods, by targeting mosquitoes in places other than human dwellings, but its effectiveness in the field will require cheap, long-lasting and easy-to-use mosquito lures.</description>
        <link>http://www.parasitesandvectors.com/content/3/1/12</link>
                <dc:creator>Fredros Okumu</dc:creator>
                <dc:creator>Edith Madumla</dc:creator>
                <dc:creator>Alex John</dc:creator>
                <dc:creator>Dickson Lwetoijera</dc:creator>
                <dc:creator>Robert Sumaye</dc:creator>
                <dc:source>Parasites &amp; Vectors 2010, 3:12</dc:source>
        <dc:date>2010-03-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-3-12</dc:identifier>
        <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2010-03-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/3/1/10">
        <title>Natural infection of the sand fly Phlebotomus kazeruni by Trypanosoma species in Pakistan </title>
        <description>The natural infection of phlebotomine sand flies by Leishmania parasites was surveyed in a desert area of Pakistan where cutaneous leishmaniasis is endemic.   Out of 220 female sand flies dissected, one sand fly, Phlebotomus kazeruni, was positive for flagellates in the hindgut.   Analyses of cytochrome b (cyt b), glycosomal glyceraldehyde phosphate dehydrogenase (gGAPDH) and small subunit ribosomal RNA (SSU rRNA) gene sequences identified the parasite as a Trypanosoma species of probably a reptile or amphibian.   This is the first report of phlebotomine sand flies naturally infected with a Trypanosoma species in Pakistan.   The possible infection of sand flies with Trypanosoma species should be taken into consideration in epidemiological studies of vector species in areas where leishmaniasis is endemic.</description>
        <link>http://www.parasitesandvectors.com/content/3/1/10</link>
                <dc:creator>Hirotomo Kato</dc:creator>
                <dc:creator>Hiroshi Uezato</dc:creator>
                <dc:creator>Hiroshi Sato</dc:creator>
                <dc:creator>Abdul Bhutto</dc:creator>
                <dc:creator>Farooq Soomro</dc:creator>
                <dc:creator>Javed Baloch</dc:creator>
                <dc:creator>Hiroyuki Iwata</dc:creator>
                <dc:creator>Yoshihisa Hashiguchi</dc:creator>
                <dc:source>Parasites &amp; Vectors 2010, 3:10</dc:source>
        <dc:date>2010-02-25T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-3-10</dc:identifier>
        <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2010-02-25T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/3/1/14">
        <title>Scientometric analysis of the world-wide research efforts concerning Leishmaniasis </title>
        <description>Background:
Leishmaniasis is a chronic disease that is found in various countries of the world. The aim of the current study was to investigate the impact of leishmaniasis on the world&apos;s research output. The present study assessed benchmarking of research output for the period between 1957 and 2006. Using large database analyses, research in the field of leishmaniasis was evaluated. Furthermore, cooperation between different countries was identified.
Results:
The number of publications increased with time. Most publications came from Western countries such as the US, UK or Germany. Interestingly, countries like Brazil and India had a high research output. We found a substantial amount of cooperation between countries.
Conclusion:
Although leishmaniasis is of limited geographic distribution it attracts a wide research interest. The central hub of research cooperation is the USA.</description>
        <link>http://www.parasitesandvectors.com/content/3/1/14</link>
                <dc:creator>K Al-Mutawakel</dc:creator>
                <dc:creator>C Scutaru</dc:creator>
                <dc:creator>A Shami</dc:creator>
                <dc:creator>M Sakr</dc:creator>
                <dc:creator>D Groneberg</dc:creator>
                <dc:creator>D Quarcoo</dc:creator>
                <dc:source>Parasites &amp; Vectors 2010, 3:14</dc:source>
        <dc:date>2010-03-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-3-14</dc:identifier>
        <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>14</prism:startingPage>
        <prism:publicationDate>2010-03-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/3/1/13">
        <title>Simplified molecular detection of Leishmania parasites in various clinical samples from patients with leishmaniasis</title>
        <description>Background:
Molecular methods to detect Leishmania parasites are considered specific and sensitive, but often not applied in endemic areas of developing countries due to technical complexity. In the present study isothermal, nucleic acid sequence based amplification (NASBA) was coupled to oligochromatography (OC) to develop a simplified detection method for the diagnosis of leishmaniasis. NASBA-OC, detecting Leishmania RNA, was evaluated using clinical samples from visceral leishmaniasis patients from East Africa (n=30) and cutaneous leishmaniasis from South America (n=70) and appropriate control samples.
Results:
Analytical sensitivity was 10 parasites/ml of spiked blood, and 1 parasite/ml of culture. Diagnostic sensitivity of NASBA-OC was 93.3% (95% CI: 76.5%-98.8%) and specificity was 100% (95% CI: 91.1%-100%) on blood samples, while sensitivity and specificity on skin biopsy samples was 98.6% (95% CI: 91.2%-99.9%) and 100% (95% CI: 46.3%-100%), respectively.
Conclusion:
The NASBA-OC format brings implementation of molecular diagnosis of leishmaniasis in resource poor countries one step closer.</description>
        <link>http://www.parasitesandvectors.com/content/3/1/13</link>
                <dc:creator>Claire Mugasa</dc:creator>
                <dc:creator>Thierry Laurent</dc:creator>
                <dc:creator>Gerard Schoone</dc:creator>
                <dc:creator>Frank Basiye</dc:creator>
                <dc:creator>Alfarazdeg Saad</dc:creator>
                <dc:creator>Sayda el Safi</dc:creator>
                <dc:creator>Piet Kager</dc:creator>
                <dc:creator>Henk Schallig</dc:creator>
                <dc:source>Parasites &amp; Vectors 2010, 3:13</dc:source>
        <dc:date>2010-03-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-3-13</dc:identifier>
        <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>13</prism:startingPage>
        <prism:publicationDate>2010-03-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/3/1/11">
        <title>Capillariaisis (Trichurida, Trichinellidae, Capillaria hepatica) in the Brazilian Amazon: low pathogenicity, low infectivity and a novel mode of transmission </title>
        <description>Background:
Human capillariasis caused by Capillaria hepatica (syn. Calodium hepaticum) is a rare disease with no more than 40 cases registered around the world. Classically, the disease has severe symptoms that mimic acute hepatitis. Natural reservoirs of C. hepatica are urban rodents (Mus musculus and Rattus novergicus) that harbor their eggs in the liver. After examining the feces of 6 riverine inhabitants ( Rio Preto area , 8o 03&apos;S and 62o 53&apos; W  to 8o 14&apos;S and 62o 52&apos;W)  of the State of Rondonia, Brazil, and identifying C. hepatica eggs in their feces, the authors decided to investigate the real dimension of these findings by looking for two positive signals.
Methods:
Between June 1st and 15th, 2008, 246 out of  304 individuals were clinically examined. Blood samples were collected, kept under -20o C, and test by the indirect immunofluorescence technique.
Results:
The first positive signal was the presence of specific antibodies at 1:150 dilution, which indicates that the person is likely to have been exposed to eggs, most likely non-infective eggs, passing through the food chain or via contaminated food (total prevalence of 34.1%). A second more specific signal was the presence of antibodies at higher titers, thus indicating true infection.
Conclusions:
The authors concluded that only two subjects were really infected (prevalence of 0.81%); the rest was false-positives that were sensitized after consuming non-embryonated eggs.The present study is the first one carried out in a native Amazonian population and indicates the presence of antibodies against C. hepatica in this population. The results further suggest that the transmission of the parasite occurs by the ingestion of embryonated eggs from human feces and/or carcasses of wild animals. The authors propose a novel mode of transmission, describing the disease as a low pathogenic one, and showing low infectivity.</description>
        <link>http://www.parasitesandvectors.com/content/3/1/11</link>
                <dc:creator>Luis Marcelo Aranha Camargo</dc:creator>
                <dc:creator>Juliana De Souza Almeida Aranha Camargo</dc:creator>
                <dc:creator>Luana Janaina De Souza Vera</dc:creator>
                <dc:creator>Pedro Di Tarique Crispim Barreto</dc:creator>
                <dc:creator>Eudes Kang Tourinho</dc:creator>
                <dc:creator>Marcia Maria de Souza</dc:creator>
                <dc:source>Parasites &amp; Vectors 2010, 3:11</dc:source>
        <dc:date>2010-02-26T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-3-11</dc:identifier>
        <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2010-02-26T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/1/1/3">
        <title>The history of African trypanosomiasis</title>
        <description>The prehistory of African trypanosomiasis indicates that the disease may have been an important selective factor in the evolution of hominids. Ancient history and medieval history reveal that African trypanosomiasis affected the lives of people living in sub-Saharan African at all times. Modern history of African trypanosomiasis revolves around the identification of the causative agents and the mode of transmission of the infection, and the development of drugs for treatment and methods for control of the disease. From the recent history of sleeping sickness we can learn that the disease can be controlled but probably not be eradicated. Current history of human African trypanosomiasis has shown that the production of anti-sleeping sickness drugs is not always guaranteed, and therefore, new, better and cheaper drugs are urgently required.</description>
        <link>http://www.parasitesandvectors.com/content/1/1/3</link>
                <dc:creator>Dietmar Steverding</dc:creator>
                <dc:source>Parasites &amp; Vectors 2008, 1:3</dc:source>
        <dc:date>2008-02-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-1-3</dc:identifier>
        <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2008-02-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/3/1/4">
        <title>Schistosomiasis vaccine discovery using immunomics</title>
        <description>The recent publication of the Schistosoma japonicum and S. mansoni genomes has expanded greatly the opportunities for post-genomic schistosomiasis vaccine research. Immunomics protein microarrays provide an excellent application of this new schistosome sequence information, having been utilised successfully for vaccine antigen discovery with a range of bacterial and viral pathogens, and malaria.Accordingly, we have designed and manufactured a Schistosoma immunomics protein microarray as a vaccine discovery tool. The microarray protein selection combined previously published data and in silico screening of available sequences for potential immunogens based on protein location, homology to known protective antigens, and high specificity to schistosome species. Following cloning, selected sequences were expressed cell-free and contact-printed onto nitrocellulose microarrays. The reactivity of microarray proteins with antisera from schistosomiasis-exposed/resistant animals or human patients can be measured with labelled secondary antibodies and a laser microarray scanner; highly reactive proteins can be further assessed as putative vaccines. This highly innovative technology has the potential to transform vaccine research for schistosomiasis and other parasitic diseases of humans and animals.</description>
        <link>http://www.parasitesandvectors.com/content/3/1/4</link>
                <dc:creator>Patrick Driguez</dc:creator>
                <dc:creator>Denise Doolan</dc:creator>
                <dc:creator>Alex Loukas</dc:creator>
                <dc:creator>Philip Felgner</dc:creator>
                <dc:creator>Donald McManus</dc:creator>
                <dc:source>Parasites &amp; Vectors 2010, 3:4</dc:source>
        <dc:date>2010-01-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-3-4</dc:identifier>
        <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2010-01-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.parasitesandvectors.com/content/3/1/16">
        <title>Synthetic sex pheromone attracts the leishmaniasis vector Lutzomyia longipalpis to experimental chicken sheds treated with insecticide</title>
        <description>Background:
Current strategies for controlling American visceral leishmaniasis (AVL) have been unable to prevent the spread of the disease across Brazil. With no effective vaccine and culling of infected dogs an unpopular and unsuccessful alternative, new tools are urgently needed to manage populations of the sand fly vector, Lutzomyia longipalpis Lutz and Neiva (Diptera: Psychodidae). Here, we test two potential strategies for improving L. longipalpis control using the synthetic sand fly pheromone (+/-)-9-methylgermacrene-B: the first in conjunction with spraying of animal houses with insecticide, the second using coloured sticky traps.
Results:
Addition of synthetic pheromone resulted in greater numbers of male and female sand flies being caught and killed at experimental chicken sheds sprayed with insecticide, compared to pheromone-less controls. Furthermore, a ten-fold increase in the amount of sex pheromone released from test sheds increased the number of females attracted and subsequently killed. Treating sheds with insecticide alone resulted in a significant decrease in numbers of males attracted to sheds (compared to pre-spraying levels), and a near significant decrease in numbers of females. However, this effect was reversed through addition of synthetic pheromone at the time of insecticide spraying, leading to an increase in number of flies attracted post-treatment.In field trials of commercially available different coloured sticky traps, yellow traps caught more males than blue traps when placed in chicken sheds. In addition, yellow traps fitted with 10 pheromone lures caught significantly more males than pheromone-less controls. However, while female sand flies showed a preference for both blue and yellow pheromone traps sticky traps over white traps in the laboratory, neither colour caught significant numbers of females in chicken sheds, either with or without pheromone.
Conclusions:
We conclude that synthetic pheromone could currently be most effectively deployed for sand fly control through combination with existing insecticide spraying regimes. Development of a standalone pheromone trap remains a possibility, but such devices may require an additional attractive host odour component to be fully effective.</description>
        <link>http://www.parasitesandvectors.com/content/3/1/16</link>
                <dc:creator>Daniel Bray</dc:creator>
                <dc:creator>Graziella Alves</dc:creator>
                <dc:creator>Maria Dorval</dc:creator>
                <dc:creator>Reginaldo Brazil</dc:creator>
                <dc:creator>J Hamilton</dc:creator>
                <dc:source>Parasites &amp; Vectors 2010, 3:16</dc:source>
        <dc:date>2010-03-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-3305-3-16</dc:identifier>
        <prism:publicationName>Parasites &amp; Vectors</prism:publicationName>
        <prism:issn>1756-3305</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>16</prism:startingPage>
        <prism:publicationDate>2010-03-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
